NCT05912426

Brief Summary

The study is a small-scale, short-term unblinded feasibility study to explore the acceptability and feasibility of implementing a reduced-sodium iodised salt intervention in Nigeria. This study will be used to inform a large-scale intervention trial comparing the effects of reduced-sodium salt versus regular salt on the rise in blood pressure with age.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 31, 2023

Completed
22 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

March 5, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2024

Completed
Last Updated

August 29, 2024

Status Verified

August 1, 2024

Enrollment Period

3 months

First QC Date

May 31, 2023

Last Update Submit

August 27, 2024

Conditions

Keywords

Reduced-sodium saltPotassium-enriched saltSalt reductionBlood pressureSaltFeasibility

Outcome Measures

Primary Outcomes (4)

  • Rate of recruitment

    Measured as the number of households recruited each month

    2 months

  • Adherence to the reduced-sodium salt intervention

    Measured as the self-reported proportion of regular salt replaced with intervention salt at each follow-up visit. The investigators will also estimate the quantity of intervention salt used by the household at each follow-up visit by visually estimating the amount of intervention salt that remains unused.

    2 months

  • Acceptability of the reduced-sodium salt intervention

    Measured as the percentage of participants that identify 'good', 'really good' or 'super good' on a brief questionnaire administered at the 2-month follow-up visit

    2 months

  • Completion rate of visits

    Measured as the percentage of participants that provide key data points (e.g., blood pressure, safety) at each visit

    2 months

Secondary Outcomes (7)

  • Total number and percentage of households eligible to participate in the study

    2 months

  • Average number of participants per household and breakdown by age group

    2 months

  • Willingness to engage in monthly follow-up visits in a longer-term trial (48-months)

    2 months

  • Systolic and diastolic blood pressure

    2 months

  • Urinary sodium concentration

    2 months

  • +2 more secondary outcomes

Study Arms (1)

Reduced-sodium potassium-enriched salt

EXPERIMENTAL

Reduced-sodium potassium-enriched salt

Behavioral: Reduced-sodium potassium-enriched salt

Interventions

Supply and use of a reduced-sodium, potassium-enriched iodised salt (66% potassium chloride, 34% sodium chloride).

Reduced-sodium potassium-enriched salt

Eligibility Criteria

Age6 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • At least one household member is a child or adolescent (6-17 years) and at least one household member is an adult (≥18 years)
  • All household members consume greater than half of meals as food prepared in the home (self-report)
  • All household members provide signed informed consent/assent (consent obtained from legal guardians for those \<18 years of age; assent also obtained from children/adolescents ≥12 years of age)

You may not qualify if:

  • Any household member has serious renal impairment.
  • Any household member uses a potassium-sparing diuretic.
  • Any household member uses a potassium supplement.
  • Any household member has other reason for concern about the use of reduced-sodium salt.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Gofidna

Abuja Municipal Area Council, Federal Capital Territory, Nigeria

Location

Jahi-2

Abuja Municipal Area Council, Federal Capital Territory, Nigeria

Location

Related Publications (1)

  • Kissock KR, Okoro C, Trieu K, Ripiye NR, Orji A, Huffman MD, Neal B, Ojji D. A feasibility study for a trial testing the effects of reduced-sodium salt on the rise in blood pressure with age. Nutr Metab Cardiovasc Dis. 2025 Oct;35(10):104129. doi: 10.1016/j.numecd.2025.104129. Epub 2025 May 11.

Study Officials

  • Katrina Kissock, PhD

    The George Institute

    STUDY CHAIR
  • Bruce Neal, PhD

    The George Institute

    PRINCIPAL INVESTIGATOR
  • Dike Ojji, PhD

    University of Abuja Teaching Hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2023

First Posted

June 22, 2023

Study Start

March 5, 2024

Primary Completion

May 20, 2024

Study Completion

May 20, 2024

Last Updated

August 29, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

Data may be used for future research purposes or shared with other researchers. Researchers wishing to obtain data for secondary research purposes must place a request with the Principal Investigator (Prof Bruce Neal) and provide a copy of their ethics approval. If the request is approved, the Principal Investigator will provide remote access to the data to other researchers via a remote data access service. All data will be made available in a de-identified format with unique participant and household Identifier (ID) numbers. Data linking participant and household IDs to identifiable participant information will not be provided.

Locations